This study is completed in the United States. It is testing Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Depression for depression in bipolarity.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AstraZeneca
Condition: Bipolarity, Depression

View study

CompletedNCT00697515

Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Shire
Condition: ADHD

View study

CompletedNCT00280566

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolarity type I (Manic or Mixed)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States, France, Chile, ...
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Bipolarity

View study

CompletedNCT02411526

Safety and PK study With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Zogenix, Inc.
Condition: Schizophrenia

View study

Active Not RecruitingNCT07275970

Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugOver 18 Years

Countries: United States
Sponsor: Scottsdale Research Institute
Condition: PTSD

View study

CompletedNCT01114737

Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 8 Years to 65 Years

Countries: United States, Canada
Sponsor: BioMarin Pharmaceutical
Condition: ADHD

View study

TerminatedNCT01122927

Safety study of aripiprazole in schizophrenia

This study was terminated in the United States, in Bulgaria, in Croatia, .... It is testing aripiprazole for schizophrenia.

In United States

Bipolarity, SchizophreniaDrugFrom 10 Years to 17 Years

Countries: United States, Bulgaria, Croatia, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Bipolarity, Schizophrenia

View study

CompletedNCT01892384

Safety and Tolerability of BI 409306 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Boehringer Ingelheim
Condition: Schizophrenia

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.